Acorah Software Products - Accounts Production 16.3.350 false true true 30 September 2023 1 October 2022 false 1 October 2023 31 December 2024 31 December 2024 11903551 Mrs Gemma Butcher Mr Joseph Butcher Ms Bethany Lampl Mr William Narey iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11903551 2023-09-30 11903551 2024-12-31 11903551 2023-10-01 2024-12-31 11903551 frs-core:CurrentFinancialInstruments 2024-12-31 11903551 frs-core:Non-currentFinancialInstruments 2024-12-31 11903551 frs-core:BetweenOneFiveYears 2024-12-31 11903551 frs-core:ComputerEquipment 2024-12-31 11903551 frs-core:ComputerEquipment 2023-10-01 2024-12-31 11903551 frs-core:ComputerEquipment 2023-09-30 11903551 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-10-01 2024-12-31 11903551 frs-core:FurnitureFittings 2024-12-31 11903551 frs-core:FurnitureFittings 2023-10-01 2024-12-31 11903551 frs-core:FurnitureFittings 2023-09-30 11903551 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2024-12-31 11903551 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2023-10-01 2024-12-31 11903551 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2023-09-30 11903551 frs-core:MotorVehicles 2024-12-31 11903551 frs-core:MotorVehicles 2023-10-01 2024-12-31 11903551 frs-core:MotorVehicles 2023-09-30 11903551 frs-core:OtherResidualIntangibleAssets 2024-12-31 11903551 frs-core:OtherResidualIntangibleAssets 2023-10-01 2024-12-31 11903551 frs-core:OtherResidualIntangibleAssets 2023-09-30 11903551 frs-core:PlantMachinery 2024-12-31 11903551 frs-core:PlantMachinery 2023-10-01 2024-12-31 11903551 frs-core:PlantMachinery 2023-09-30 11903551 frs-core:WithinOneYear 2024-12-31 11903551 frs-core:SharePremium 2024-12-31 11903551 frs-core:ShareCapital 2024-12-31 11903551 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 11903551 frs-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-12-31 11903551 frs-bus:FilletedAccounts 2023-10-01 2024-12-31 11903551 frs-bus:SmallEntities 2023-10-01 2024-12-31 11903551 frs-bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-12-31 11903551 frs-bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-12-31 11903551 frs-bus:Director1 2023-10-01 2024-12-31 11903551 frs-bus:Director1 2023-09-30 11903551 frs-bus:Director1 2024-12-31 11903551 frs-bus:Director2 2023-10-01 2024-12-31 11903551 frs-bus:Director2 2023-09-30 11903551 frs-bus:Director2 2024-12-31 11903551 frs-bus:Director3 2023-10-01 2024-12-31 11903551 frs-bus:Director4 2023-10-01 2024-12-31 11903551 frs-bus:Director4 2023-09-30 11903551 frs-bus:Director4 2024-12-31 11903551 frs-countries:EnglandWales 2023-10-01 2024-12-31 11903551 2022-09-30 11903551 2023-09-30 11903551 2022-10-01 2023-09-30 11903551 frs-core:CurrentFinancialInstruments 2023-09-30 11903551 frs-core:Non-currentFinancialInstruments 2023-09-30 11903551 frs-core:BetweenOneFiveYears 2023-09-30 11903551 frs-core:WithinOneYear 2023-09-30 11903551 frs-core:SharePremium 2023-09-30 11903551 frs-core:ShareCapital 2023-09-30 11903551 frs-core:RetainedEarningsAccumulatedLosses 2023-09-30
Registered number: 11903551
Certus Biomedical Ltd
Unaudited Financial Statements
For the Period 1 October 2023 to 31 December 2024
Linggard and Thomas
Kew An Lergh
Stret Mygthern Arrthur
Nansledan
TR8 4UX
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—6
Page 1
Balance Sheet
Registered number: 11903551
31 December 2024 30 September 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 15,047 17,631
Tangible Assets 5 332,193 402,775
347,240 420,406
CURRENT ASSETS
Stocks 6 511,608 330,191
Debtors 7 61,650 349,746
Cash at bank and in hand 2,586 22,312
575,844 702,249
Creditors: Amounts Falling Due Within One Year 8 (637,381 ) (372,180 )
NET CURRENT ASSETS (LIABILITIES) (61,537 ) 330,069
TOTAL ASSETS LESS CURRENT LIABILITIES 285,703 750,475
Creditors: Amounts Falling Due After More Than One Year 9 (553,006 ) (964,247 )
NET LIABILITIES (267,303 ) (213,772 )
CAPITAL AND RESERVES
Called up share capital 11 101 100
Share premium account 541,093 -
Profit and Loss Account (808,497 ) (213,872 )
SHAREHOLDERS' FUNDS (267,303) (213,772)
Page 1
Page 2
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Joseph Butcher
Director
23/05/2025
The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Certus Biomedical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11903551 . The registered office is Unit 7c A30 Business Park, Indian Queens, Newquay, TR9 6FZ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The directors have assessed the Balance sheet and future cash flows of the company. The Company is supported through loans from the Parent Company. The directors have received assurances that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the Parent Company will continue to support the Company. After making enquiries, the directors believe that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.4. Intangible Fixed Assets and Amortisation - Other Intangible
Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation begins once the asset has been brought into use. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:
Other intangible assets -  20% reducing balance
2.5. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Leasehold Not Depreciated
Plant & Machinery 20% Reducing balance
Motor Vehicles 20% Reducing balance
Fixtures & Fittings 20% Reducing balance
Computer Equipment 20% Reducing balance
2.6. Leasing and Hire Purchase Contracts
Assets obtained under finance leases are capitalised as tangible fixed assets. Assets acquired under finance leases are depreciated over the shorter of the lease term and their useful lives. Assets acquired under hire purchase contracts are depreciated over their useful lives. Finance leases are those where substantially all of the benefits and risks of ownership are assumed by the company. Obligations under such agreements are included in the creditors net of the finance charge allocated to future periods. The finance element of the rental payment is charged to the profit and loss account so as to produce a constant periodic rate of charge on the net obligation outstanding in each period.
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged to profit and loss account as incurred.
Page 3
Page 4
2.7. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
3. Average Number of Employees
Average number of employees, including directors, during the period was: 22 (2023: 16)
22 16
4. Intangible Assets
Other
£
Cost
As at 1 October 2023 19,500
Additions 2,168
As at 31 December 2024 21,668
Amortisation
As at 1 October 2023 1,869
Provided during the period 4,752
As at 31 December 2024 6,621
Net Book Value
As at 31 December 2024 15,047
As at 1 October 2023 17,631
5. Tangible Assets
Land & Property
Leasehold Plant & Machinery Motor Vehicles Fixtures & Fittings
£ £ £ £
Cost
As at 1 October 2023 3,737 225,595 197,619 68,653
Additions 5,044 7,541 - 11,425
As at 31 December 2024 8,781 233,136 197,619 80,078
Depreciation
As at 1 October 2023 - 50,063 33,445 10,585
Provided during the period 1,464 43,485 39,402 16,694
As at 31 December 2024 1,464 93,548 72,847 27,279
Net Book Value
As at 31 December 2024 7,317 139,588 124,772 52,799
As at 1 October 2023 3,737 175,532 164,174 58,068
Page 4
Page 5
Computer Equipment Total
£ £
Cost
As at 1 October 2023 1,408 497,012
Additions 8,496 32,506
As at 31 December 2024 9,904 529,518
Depreciation
As at 1 October 2023 144 94,237
Provided during the period 2,043 103,088
As at 31 December 2024 2,187 197,325
Net Book Value
As at 31 December 2024 7,717 332,193
As at 1 October 2023 1,264 402,775
6. Stocks
31 December 2024 30 September 2023
£ £
Stock 511,608 330,191
7. Debtors
31 December 2024 30 September 2023
£ £
Due within one year
Trade debtors 55,895 283,431
Other debtors 5,755 66,315
61,650 349,746
8. Creditors: Amounts Falling Due Within One Year
31 December 2024 30 September 2023
£ £
Net obligations under finance lease and hire purchase contracts 5,994 16,483
Trade creditors 108,178 37,892
Other loans 89,444 152,177
Other creditors 356,170 105,664
Taxation and social security 77,595 59,964
637,381 372,180
Page 5
Page 6
9. Creditors: Amounts Falling Due After More Than One Year
31 December 2024 30 September 2023
£ £
Net obligations under finance lease and hire purchase contracts 71,468 81,868
Other loans 115,052 170,370
Other creditors 366,486 712,009
553,006 964,247
10. Obligations Under Finance Leases and Hire Purchase
31 December 2024 30 September 2023
£ £
The future minimum finance lease payments are as follows:
Not later than one year 5,994 16,483
Later than one year and not later than five years 71,468 81,868
77,462 98,351
77,462 98,351
11. Share Capital
31 December 2024 30 September 2023
£ £
Allotted, Called up and fully paid 101 100
12. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 October 2023 Amounts advanced Amounts repaid Amounts written off As at 31 December 2024
£ £ £ £ £
Mrs Gemma Butcher 32,004 21,508 (52,161 ) - 1,351
Mr Joseph Butcher 32,004 21,508 (52,161 ) - 1,351
Mr William Narey (135,061 ) 144,103 (410,637 ) - (401,595 )
The above loan is unsecured, interest free and repayable on demand.
13. Related Party Transactions
Global Inhalation Equipment Limited 2024: £73,477, (2023: £616,009)
Somni-Gas Ltd 2024: £98,420, (2023: £20,322)
Hypneuma Limited   2024: £nil, (2023: £33,358)
Included in Creditors due less than one year are amounts due to Global Inhalation Equipment ltd £Nil (£73,476).
Page 6